Ezekiel Emanuel on the Practice of Medicine, Policy, and Life

Ezekiel Emanuel — oncologist, bioethicist, and one of the principal architects of the Affordable Care Act — joins Tyler Cowen in Ep. 67 to argue that American medicine overvalues IQ and undervalues emotional intelligence, that the physician shortage is a myth, that medical education is decades out of date, and that the case for living past 75 is weaker than most people admit.

Key ideas

1. Emotional intelligence, not IQ, is what medicine most needs. Eighty-six cents of every healthcare dollar goes to people with chronic illness, and managing chronic illness is fundamentally a behaviour-change problem. Technical brilliance cannot persuade a diabetic patient to change their diet; emotional attunement can. Doctors who overindex on intelligence and underindex on empathy are optimising for the wrong thing.
2. The physician shortage is a manufactured claim. Running the arithmetic on office visits, primary-care doctors, and available appointment time shows no structural gap — the real problem is misallocation: too much in-office work that could be done by phone, text, or lower-credentialled staff. More doctors would not improve care; through supply-induced demand, they would raise costs.
3. Medical school has not been meaningfully updated since 1910. Preclinical curricula still teach the Krebs cycle and viral taxonomy that practising physicians never use. Emanuel’s prescription: compress preclinical work (increasingly migrating online anyway), shift clinical training out of hospitals (where the future of medicine is not), and require more philosophy, history, and behavioural science instead.
4. The ‘75 essay’ is about cognitive and creative decline, not just dying. Emanuel’s much-contested argument that he would not aggressively extend his life past 75 rests on neurological observation: creativity and genuine novelty in thinking decline steeply after that age in almost everyone. The NBA Finals and the latest political drama are not sufficient reasons to hang on — they are symptoms of a life that has coned down to small things.
5. The ACA and healthcare costs require structural fixes, not incremental ones. Hospital mergers have created local monopolies that extort private insurers; antitrust enforcement or price caps are needed. Malpractice reform matters, but not in the form conservatives propose — safe harbours and the Michigan apology-and-disclosure model are better. And individual autonomy has been so over-weighted in American bioethics that it crowds out the economic and social consequences of individual choices for everyone else.

Content

IQ versus emotional intelligence in doctors

Cowen opens by asking whether we overrate IQ for doctors. Emanuel’s answer is direct: yes. The dominant challenge in contemporary medicine is chronic illness — conditions patients will live with indefinitely, where the physician’s primary task is to persuade behaviour change. That requires relating to patients, reading them accurately, and motivating them. None of it is about intelligence in the conventional sense. He notes that emotional intelligence does not come naturally to him; he has had to cultivate it deliberately, in contrast to his brothers.

Community healthcare workers, Emanuel observes, often exhibit the highest emotional intelligence of any clinical group: selected precisely for listening, problem-solving, and genuine care, they outperform credentialled clinicians on the dimension that matters most for chronic-disease management.

On whether there is a shortage of physicians: the Association of American Medical Colleges and most medical establishments worldwide claim one, but the arithmetic does not support it. Counting existing primary-care doctors against total primary-care visits, assuming reasonable appointment lengths, shows the supply is adequate. The real dysfunction is structural — too many visits that need not happen in person, tasks done by doctors that nurses or medical assistants could handle, and a reimbursement system that pushes physicians toward volume rather than efficiency. Supply-induced demand means more doctors would likely increase costs rather than improve access.

Medical education — what to cut and what to add

Medical school’s two-years-preclinical, two-years-clinical structure dates from the Flexner Report of 1910. Emanuel’s critique is systematic: the preclinical material (viral taxonomy, the Krebs cycle, biochemical pathways) is largely irrelevant to practice and outdated by the time students graduate. Two-thirds of students already watch recorded lectures rather than attending in person. The logical trajectory is to move preclinical content online before medical school begins, freeing the school years for clinical training.

The clinical rotations themselves are also misplaced: concentrated in hospitals, when American medicine’s future is overwhelmingly outpatient. No medical school has made that shift yet, but Emanuel expects it within 15 years.

On whether undergraduates need a degree before medical school: yes — not for skills or knowledge, but for the self-understanding that comes from studying history, literature, philosophy, psychology, and behavioural economics. The premed prerequisites (organic chemistry foremost) are, in his word, ridiculous. What Emanuel would substitute is the liberal arts curriculum, which prepares a doctor to understand the social, cultural, and economic context of patients’ lives.

Bioethics — autonomy, informed consent, and the FDA

Emanuel traces his bioethical method to an inductive habit: work out the intuitively right answer to a specific situation, then identify the principles that got you there. His recurring finding is that conventional wisdom overemphasises one value — and for the past 40 years, that value has been individual autonomy.

Autonomy over-emphasis has two costs. First, it detaches individuals from the social networks — family, community, religious community — that shape and sustain their choices. Second, it ignores the economic and political externalities: spending a lot on one patient’s care means not spending it on another; allocating an organ to one person is denying it to someone else. Emanuel has spent much of his career widening the value set and trying to prioritise it honestly.

On informed consent: he agrees with Cowen’s observation that in low-trust societies it is largely meaningless. More broadly, he thinks American healthcare relies too heavily on the fiction that patients can evaluate risk-benefit ratios if given enough information. They cannot — any more than an ordinary traveller can inspect a plane before boarding. Institutional oversight, not individual consent, is the primary protection.

On the FDA and the ‘right to try’: he is sharply opposed. The libertarian argument — that it is my body, I should be able to try whatever I want — fails to account for the societal benefit of having proven-safe-and-effective drugs as the baseline. Nutritional supplements, deregulated under pressure from the Utah congressional delegation, have caused deaths precisely because oversight was removed. He prefers compassionate use as a limited, structured exception, and is even sceptical of that.

On institutional review boards: they spend too much time on informed-consent paperwork and not enough on the thing that actually protects participants — the risk-benefit ratio of the protocol. He also argues for consolidating multi-site trials under a single IRB rather than requiring each institution to review the same protocol independently; the duplication wastes time and money with no safety gain.

The ‘75 essay’ and end-of-life reasoning

Emanuel’s 2014 Atlantic essay — ‘Why I Hope to Die at 75’ — generated enormous controversy and repeated misreading. The argument is not that life after 75 has no value, or that others should stop treatment; it is that he personally would not pursue aggressive life extension past that age.

The underlying reason is neurological: creativity, genuine novelty of thought, and cognitive plasticity decline sharply after 75 for almost everyone. Benjamin Franklin — the most creative person born on the North American continent, in Emanuel’s assessment — shows the pattern. After 75, even Franklin’s output slows and narrows. The parts of the brain exercised repeatedly become highly efficient; the parts not exercised atrophy; plasticity diminishes.

Cowen presses the ‘intransitivity of indifference’ objection: there is always something — the NBA Finals, the Mueller report — that makes this particular moment worth staying for. Emanuel concedes the psychology: we cone down, come to overvalue small things, and use them as reasons not to let go. His response is to step back and ask, from a 2,000-foot view, whether these are really sufficient reasons — and his answer is that they are not, for him.

He does regard immortality as both probably achievable within a century and deeply undesirable — not primarily for social reasons, but because a permanently creative, genuinely novel existence seems neurologically implausible for any mind running in a biological substrate over a very long time. His brother, a Hollywood agent, puts it more bluntly: we still cannot cure back pain or the common cold.

Healthcare costs and structural reform

The conversation covers several levers for bringing down healthcare spending. On hospital consolidation: too many mergers have created local monopolies able to extract premium rates from private insurers who have no alternative network to offer. Emanuel supports both antitrust action and, if antitrust is not forthcoming, hard caps on what hospitals can charge.

On malpractice: he thinks it matters less than doctors and conservatives claim, but the standard reform proposals — limiting filing periods, capping non-economic damages — are the wrong ones. Better alternatives are safe-harbour provisions (a doctor following approved protocols is presumed not negligent) and the University of Michigan’s disclosure-and-apology model, which reduces litigation by removing the adversarial frame.

On pharmaceuticals: he is sceptical that a $3,000 drug adding a statistical year of life at the end of a long life represents good value relative to alternatives. Drug pricing is a legitimate target, as are misaligned payment structures that reward volume rather than outcomes.

He also pushes back on using life expectancy as the primary metric for evaluating healthcare. The social determinants — education, housing, income equality — are the dominant drivers of longevity. A $3.5 trillion healthcare system operating at the end of causal chains, after chronic conditions have already set in, is not the most cost-effective lever; it merely carries the highest price tag.

Overrated and underrated

Joseph Warren: massively underrated. Organiser of Paul Revere’s ride, chair of nearly every Boston revolutionary committee, likely future president — killed at Bunker Hill and largely forgotten. Alesund, Norway: underrated; the kayaking is world-class. Madagascar: overrated; underwhelming wildlife and infrastructure relative to other African destinations. Travel as a means of understanding the world: underrated — Emanuel’s father, a newly immigrated Israeli doctor with limited money, prioritised international travel over consumer goods, and Emanuel credits it with his capacity to understand complexity. Free-range parenting: overrated; children need known limits and freedom within them, which is not the same thing as free range.

On food: Aspen has no good restaurants despite concentrating extraordinary wealth — Emanuel suspects supply-side constraints (rent, seasonality). He makes his own chocolate, sourcing criollo beans from Ecuador and roasting light to preserve volatile organics; his favourite movie is Some Like It Hot (1959); and he prefers experiences over material possessions as the unit of a rich life.

Related

• Ezekiel Emanuel — guest; oncologist, bioethicist, and health-policy scholar
• Tyler Cowen — host